ICB/ICS development and how it impacts on the roles of High Cost Medicines Pharmacists and Medicines Value Teams
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
PM Healthcare events are Quality Assured by the University of Bradford
| Event Name | ICB/ICS development and how it impacts on the roles of High Cost Medicines Pharmacists and Medicines Value Teams | |||
| Location | Virtual | |||
| Start Date | 12:30pm 25/09/2024 | |||
| Finish Date | 2:00pm 25/09/2024 | |||
| Booking Closes | 11:30am 25/09/2024 - Closing Soon! | |||
| Places | Available | |||
| Event Description | ||||
|
This event has been organised by PM Healthcare and funded by Roche Products Ltd. It may contain discussions about Roche Medicines within sections of the meeting. M-GB-00018990 | September 2024
Sessions & Speakers: Panel Discussion: The environment – current and future facingTase Oputu Associate Director of Medicines Optimisation, Medicines Value & Performance NHS Kent & Medway Integrated Care Board Jas Khamb Chief Pharmacist & Clinical Director NHS London Procurement Partnership
An update on latest and planned developmentsStephen Goudrey-Smith Pharmacy Informatics Specialist SGS PharmaSolutions
Sponsored Session: Working in partnership: How could health systems strike a balance between allowing treatment choice and managing capacity constraints while meeting financial targets?Aires Lobo Consultant Ophthalmologist - Bedford Hospital David Reith Director Healthcare Services - Newmarket Strategy
| ||||
| Agenda | Download Agenda PDF | |||
| Contact Name | Tara Kendrick | |||
| More Details | Email for more details. | |||
| Your booking is always provisional until we confirm it! | ||||
| Login | Create Account |
